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INTRODUCTION
The kidneys perform an important task by regulating intravas-
cular volume and electrolyte balance in the body. Under normal 
circumstances, the kidneys receive approximately one-fourth of 
the cardiac output (1).
Ischemic renal injury is frequently encountered after trauma, seri-
ous hypovolemia, severe sepsis, burns, and major surgical inter-
ventions. Injury in the ischemic kidney occurs not only during the 
ischemic period but also during the subsequent reperfusion pe-
riod. After major surgical intervention, renal functions are widely 
influenced from minimal natriuresis to fulminant acute renal in-
sufficiency that could progress to dialysis (1, 2). Preserving renal 
function in patients who undergo cross-clamping over the renal 
arteries during aortic surgery is closely associated with patient 
age, ischemia duration, and preoperative renal functions. 
In the present study, hemodynamic parameters, biochemical 
changes, and primarily the cytopathological effects of L-arginine 
in renal ischemia were investigated in a renal ischemia model. 
METHODS
In the present study, 40 New Zealand rabbits weighing between 
2150 grams (g) and 3450 g were used. The study was conducted 
in line with Experimental Medicine Training and Research Cen-
ter, Directives of Ethics Committee for Experimental Animals, 
which have been prepared based on the Universal Declaration 
on Animal Welfare, European Convention for the Protection of 
Vertebrate Animals used for Experimental and Other Scientific 
Purposes, and the Guide for the Care and Use of Laboratory Ani-
mals. Moreover, the study was conducted at the Experimental 
Medicine Training and Research Center after the approval of eth-
ics committee of Selçuk University Meram School of Medicine. In 
the present study, 30 min, which is the minimum time for cross-
clamping to be tolerated without complication under normother-
mic conditions, was taken as the basis.
Groups
The rabbits included in the study were divided into two groups 
as the control group (Group 1) and L-arginine group (Group 2), 
with each group including an equal number of rabbits. While the 
weight of the rabbits was between 2150 g and 3200 g in Group 1, 
it was between 2250 g and 3450 g in Group 2.
Thirty-minute suprarenal occlusion was performed in all animals. 
The rabbits in both groups received an isotonic fluid (Mediflex® 
0.9% NaCl, Eczacıbaşı-Baxter, İstanbul, Turkey) infusion at a dos-
age of 4 milliliters (mL)/kilograms (kg)/hours (h) over the course 
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ABSTRACT
Objective: In this study, we investigated the effect of L-arginine on hemodynamic, biochemical, and histopathological changes in a rabbit 
model with renal ischemia.
Methods: Forty white New Zealand rabbits were used. The rabbits were divided into two groups as the control group (n=20) and L-arginine 
group (n=20). They were monitored by cannulating the auricular and femoral arteries. An aortic occlusion catheter was inserted through 
the contralateral femoral artery and was extended to the distal aspect of the left subclavian artery; it was then inflated, and occlusion was 
performed for 30 min. All rabbits received 4 mL/kg/h of NaCl infusion during the course of occlusion and within the first 60 min of reperfusion. 
In the L-arginine group, L-arginine was infused at a dosage of 3 mg/kg/h through the auricular vein during the first 60 min of occlusion and 
perfusion. Blood samples for biochemical parameters [glucose, lactate, hematocrit, blood urea nitrogen (BUN), and serum creatinine] were 
obtained in the peri-ischemic period, in the 20th minute of reperfusion, and just before sacrificing (48th hour). A histopathological examination 
was performed in both renal tissues. Histopathological scoring was performed by taking tubular epithelial cell flattening, brush border loss, 
cytoplasmic vacuolization, cell necrosis, and tubular lumen obstruction into consideration. All animals were sacrificed 48 h after the procedure.
Results: A significant difference was found between the L-arginine and control groups in terms of the hemodynamic outcomes and 48th hour 
BUN and serum creatinine levels (p<0.05). The histopathological examination revealed a mean score of 3.2±0.89 in the control group and 
2.60±0.68 in the L-arginine group (p<0.05) (p=0.022).
Conclusion: It can be suggested that L-arginine reduces renal ischemia–reperfusion injury and in particular, the histopathological effects. 
(JAREM 2016; 6: 24-30)
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of the procedure and for 60 minutes (min) after the clamp was 
removed. In the L-arginine group (n=20), L-arginine, which had 
been diluted using 10-mL distilled water, was administered at a 
dosage of 3 mg/kg/h as an intravenous continuous infusion from 
the onset of aortic occlusion to the end of 60 min following the 
removal of the aortic clamp.
Anesthesia and Monitoring
Intramuscular ketamine hydrochloride (50 mg/kg) (Ketalar® 
Pfizer, Paris, France) and xylazine (10 mg/kg) (Xylazinbio® 2% 
Bioveta, Ankara, Turkey) were administered to the animals. The 
dose was repeated as a cocktail containing ketamine (25 mg/kg) 
and xylazine (5 mg/kg) when necessary. After the anesthesia, the 
animals were left for spontaneous breathing and were provided 
with nasal oxygen (O2) support at a dose of 2 liters (l)/min. An in-
travenous catheter (24 gauge) was placed in each rabbit through 
the marginal ear vein. Over the course of the procedure, a 0.9% 
sodium chloride (NaCl) solution was infused at a rate of 4 mL/
kg/h. A catheter (22 gauge) was placed into the ear artery, and 
another catheter (20 gauge) was placed into the right femoral 
artery via surgical exploration to monitor blood pressure. The an-
terior thoracic area was shaved. Electrocardiography (ECG) was 
performed with electrodes placed on the anterior thoracic wall; 
blood pressures, including proximal (via the ear artery catheter) 
and distal (via the femoral artery catheter), were monitored by 
connecting the catheter placed into the ear artery to the pres-
sure transducer (Mennen medical incorporated, Model: Mercury, 
Revohot, Israel). In this way, all rabbits were continuously moni-
tored during the surgical procedure, before aortic clamping, and 
after declamping.
Surgical Procedure
The rabbits were placed on the operating table in the supine po-
sition. Sacrificing was planned to be performed after a 48-h moni-
toring period. The left femoral arteries of the rabbits were ex-
plored and suspended by tapes. Arteriotomy was performed in 
the left femoral artery 5 min after causing anticoagulation in the 
the animals with standard heparin (Nevparin® Mustafa Nevzat, 
Ankara, Turkey) at a dose of 100 units (U)/kg. An aortic occlu-
sion catheter (3 French, Promited Laboratories, Ref No: 2211100, 
Meuilly-En-Thelle, France) was pushed through the femoral ar-
tery to the approximately 22 centimeter (cm) proximal aspect (up 
to the distal aspect of the left subclavian artery). The occlusion 
catheter cuff was inflated and a decrease in the distal aortic pres-
sure was observed. Aortic occlusion was performed for 30 min in 
this way in all animals. At the end of this period, the catheter cuff 
was deflated, and an increase in the distal blood pressure was 
observed from the right femoral artery cannula. Thereafter, the 
occlusion catheter was pulled back, and pulsatile flow in the left 
femoral artery was observed. The layers were duly closed with 
appropriate suture materials. 
Postoperative Care
The rabbits were put in cages after they woke up. They were al-
lowed to be fed in the postoperative 6th hour. The bladders of the 
paraplegic animals were emptied by the Crede maneuver, which 
was performed at least two times daily. 
Sacrificing
At the end of 48 h, all rabbits were sacrificed after the renal his-
topathological samples were obtained. Sacrificing was done with 
intracardiac 10% formaldehyde after administering intramuscular 
ketamine (50 mg/kg) and xylazine (10 mg/kg).
Histopathological Evaluation
The excised tissues were put into a 10% neutral formaldehyde 
solution and were stored in this way until the time of study. The 
sections were obtained and stained with hematoxylin–eosin and 
were then examined under a light microscope by the pathologist 
from the SUM Faculty of Medicine, who was blinded. In the pres-
ent study, pathological examination under the light microscope 
was performed to investigate ischemia-related alterations in the 
kidney tissue. The scoring performed by Rhoden et al. (3) who 
took ischemia-related changes in tubular epithelial cells as the 
basis was used. 
According to this scoring, alterations in tubular epithelial cells 
and tubule structure are taken into account. Scoring was as fol-
lows: 1 point for tubular epithelial cell flattening (Figure 1), 1 point 
for brush border loss (Figure 2), 1 point for cytoplasmic vacuoliza-
tion (Figure 3), 1 or 2 points for cell necrosis (2 if it is widespread 
in the section area and 1 if it is less) (Figure 4), and 1 or 2 points 
for tubular lumen obstruction (2 if it is widespread in the section 
area and 1 if it is less) (Figure 4). 
Statistical Analysis
Data were transferred to electronic media. Statistical analyses 
were done by the SPSS program (SPSS Inc.; Chicago, IL, USA). 
Among the data collected from the rabbit groups, those not dis-
tributed normally were evaluated by Kolmogorov–Smirnov test. 
The data were compared by Mann–Whitney U test. The level of 
statistical significance was considered to be p<0.05.
RESULTS
A total of 40 New Zealand rabbits were used in the study. The 
weights of the rabbits ranged from approximately 2200 g (mini-
mum) to 3500 g (maximum). The difference between the proximal 
mean arterial blood pressure (pMAP) in the 10th and 30th minutes 
of ischemia in both groups was statistically significant (p<0.05), 
whereas the difference between the distal mean arterial blood 
pressure (dMAP) was not statistically significant (p>0.05). In the 
peri-ischemic period, it was observed that the heart rate was 
higher in the L-arginine group than in the control group (p<0.05). 
A sudden increase in pMAP and sudden decrease in dMAP were 
simultaneously determined with aortic occlusion in both groups. 
The heart rate showed a sudden decrease simultaneously with 
aortic occlusion in all rabbits. Over the course of the ischemic pe-
riod, it was observed that the difference in terms of dMAP was not 
statistically significant in both groups (p>0.05), whereas the heart 
rate was found to be higher in the 10th minute of ischemia in the 
L-arginine group (p<0.05). After the end of aortic occlusion, while 
a decrease was observed in pMAP, an increase was observed in 
dMAP in both groups during the reperfusion period compared 
with that during the ischemic period. The heart rate increased in 
the reperfusion period compared with that in the ischemic period 
in all rabbits. In the reperfusion period, the difference between 
the groups in terms of pMAP and dMAP was found to be sta-
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tistically insignificant. It was determined that the heart rate was 
statistically significantly higher in the L-arginine group than in the 
control group in the reperfusion period (p<0.05).
The pH in the 20th minute of ischemia was higher in the L-arginine 
group than in the control group, and it was found to be statisti-
cally significant (p<0.05). A lower pH in the L-arginine group than 
Figure 3. Cytoplasmic vacuolization (HE ×40)
Figure 5. BUN levels according to groups in some periods. Group 
1-blue (1: pre-ischemic period, 2: 20th minute in the reperfusion period, 
3: 48th hour in the postoperative period). Group 2-red (4: pre-ischemic 
period, 5: 20th minute in the reperfusion period, 6: 48th hour in the 
postoperative period) 
Figure 4. Tubular lumen obstruction (HE ×40) 
Figure 1. Tubular epithelial cell flattening (HE ×40)
Figure 2. Loss of brush border (HE ×40)
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in the control group during the reperfusion period was found 
to be statistically significant (p>0.05). Blood acidity (pH), blood 
urea nitrogen (BUN), serum creatinine (Scr), arterial partial carbon 
dioxide pressure (pCO2), arterial partial oxygen pressure (pO2), 
blood glucose, and blood lactate levels and hematocrit (hct) of 
all rabbits in the L-arginine and control groups are demonstrated 
in Table 1 and Table 2. BUN, Scr, pH, and lactate levels according 
to the groups are shown in Figures 5, 6, 7 and 8.
DISCUSSION
In the present study, a significant difference was found between 
the L-arginine and control groups in terms of some hemody-
namic parameters (pMAP in the 10th and 30th minutes of ischemia 
and heart rate in the pre-ischemic period) and 48th-hour BUN 
and creatinine levels (p<0.05). The histopathological examina-
tion revealed a mean score of 3.2±0.89 in the control group and 
2.60±0.68 in the L-arginine group (p<0.05) (p=0.022).
Acute renal injury due to ischemia and reperfusion (I/R) is a clini-
cal and experimental consequence characterized by a decrease 
in the glomerular filtration rate, extensive tubular injury, tubular 
cell necrosis, and obstruction due to hyaline debris. Acute tubu-
lar necrosis can be created by hypoperfusion or by completely 
interrupting the renal blood flow. In clinical practice, suprarenal 
aortic aneurism surgery is a good example for an injury caused 
by ischemia due to renal blood flow interruption and subsequent 
reperfusion. 
Lahera et al. (4) performed hemodynamic examinations to keep 
renal injury at a minimum level and demonstrated a mean de-
crease of 10%–15% in blood pressure following L-arginine 
infusion in rats. In another study conducted in rats, Waz et al. 
(5) determined a decrease in urine volume and urinary sodium 
excretion 60 min after low-dose L-NAME (0.1–1.0 µg/kg/min) 
infusion, which is a nitric oxide synthase (NOS) inhibitor. It was 
reported that high-dose L-NAME (10–50 µg/kg/min) infusion in-
creases systemic blood pressure by decreasing the renal blood 
flow and glomerular filtration rate. Bhardway and Moore (6) dem-
onstrated that L-arginine decreases renal vascular resistance but 
notably increases post-ischemic renal functions. The protective 
effect of L-arginine results from the ability of nitric oxide (NO) to 
prevent leukocyte accumulation and its vasodilator effect during 
ischemia (7).
The kidneys are more sensitive than other organs against the 
inhibition of NO production by L-NAME. A decrease in NO 
production leads to a decrease in glomerular flow, diuresis, 
and natriuresis (8). Kobayashi et al. (9) reported a remarkable 
decrease in renal blood flow in rats by administering L-NAME 
and prevented this by administering L-arginine. Another study 
demonstrated that L-NAME administration in rats remarkably 
decreases creatinine clearance (8). 
Basal NO production is necessary for the maintenance of normal 
glomerular filtration and during the renal I/R period. The inhibi-
tion of NO enhances renal dysfunction (8). During renal I/R, NO 
production is decreased due to endothelial cell injury. After the 
inhibition of NO synthase, a notable increase is observed in cre-
atinine levels in the 24th, 96th, and 192nd hours of renal I/R (8).
Many studies have stated that NO has favorable effects on re-
nal tissue in I/R. Paller et al. (10) demonstrated that NO protects 
ischemic tissue via its vasodilator effect and decreases leukocyte 
adhesion, neutrophil infiltration, and inflammatory mediator for-
mation during ischemia–reperfusion. During reoxygenation, NO 
reacts with superoxide and prevents the formation of additional 
Figure 7. pH according to groups in some periods. Group 1-blue 
(1: pre-ischemic period, 2: 20th minute in the ischemic period, 3: 20th 
minute in the reperfusion period). Group 2-red (4: pre-ischemic period, 
5: 20th minute in the ischemic period, 6: 20th minute in the reperfusion 
period) 
Figure 6. Creatinine levels according to groups in some periods. 
Group 1-blue (1: pre-ischemic period, 2: 20th minute in the reperfusion 
period, 3: 48th hour in the postoperative period). Group 2-red (4: pre-
ischemic period, 5: 20th minute in the reperfusion period, 6: 48th hour 
in the postoperative period) 
Figure 8. Lactate levels according to groups in some periods. Group 
1-blue (1: pre-ischemic period, 2: 20th minute in the ischemic period, 
3: 20th minute in the reperfusion period). Group 2-red (4: pre-ischemic 
period, 5: 20th minute in the ischemic period, 6: 20th minute in the 
reperfusion period)
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oxygen radicals such as hydroxyl and hydrogen peroxide (10). The 
increased superoxide due to a higher production of superoxide 
or impaired NO synthesis gets converted to hydrogen peroxide 
(8). The production of proinflammatory lipid mediators, such as 
platelet-activating factor and leukotriene B4, results in enhanced 
leukocyte adhesion and enhanced tissue injury in I/R (8).
Ischemia-related acute renal insufficiency is a complex syndrome 
comprising renal vasoconstriction, extensive tubular injury, tubu-
lar cell necrosis, impaired glomerular filtration, and glomerular 
injury (3-11). Decrease in the oxidative phosphorylation of the 
mitochondria, secretion of lysosomal enzymes, loss of mem-
brane functions, and increase in tubular permeability occur due 
to ischemia–reperfusion in the renal tissue. Renal oxidative stress 
due to reoxygenation may theoretically result in injury in renal 
endothelial cells, glomerular mesenchymal cells, and tubular 
epithelial cells. Consequently, both renal structure and function 
are influenced (12). Renal cells contain different antioxidant en-
zyme systems such as superoxide dismutase and catalase, which 
reduce oxidative stress injury. Endothelial cell injury that results 
from renal I/R decreases NO production. NO inhibition further 
increases renal dysfunction (8).
It has been reported that NO decreases renal vascular resistance 
and facilitates renal function return after ischemic injury (13). Cara-
melo et al. (14) administered superoxide dismutase together with 
L-arginine and demonstrated that there is a remarkable increase 
in renal functions and urine volume and that this arises from the 
synergistic effects of these two substances. Burra et al. (15) ex-
pressed that L-arginine therapy reduces histopathological injury in 
pigs that have been exposed to renal I/R. In another study, Weight 
et al. (16) emphasized that L-NAME causes no significant altera-
tion in the histology in rats that underwent renal I/R. Schneider et 
al. (17) suggested that in vivo acute L-arginine administration has 
   Group 2 
 Group 1 (L-arginine) p
pMAP (mmHg) (Pre-ischemic period) 60.20±3.33 60.85±3.48 0.55
dMAP (mmHg) (Pre-ischemic period) 60.30±3.45 61.35±3.22 0.326
pMAP (mmHg) (10th minute in the ischemic period) 97.75±3.75 94.90±3.09 0.013*
dMAP (mmHg) (10th minute in the ischemic period) 10.25±2.22 9.20±1.54 0.09
dMAP (mmHg) (30th minute in the ischemic period)  10.70±1.89 10.95±1.93 0.682
pMAP (mmHg) (10th minute in the reperfusion period) 51.80±4.07 56.55±5.26 0.3
dMAP (mmHg) (10th minute in the reperfusion period)  55.00±5.76 56.60±5.69 0.382
pMAP (mmHg) (30th minute in the reperfusion period) 44.95±5.45 45.95±10.49 0.71
dMAP (mmHg) (30th minute in the reperfusion period)  48.40±5.48 50.50±4.41 0.190
Heart rate (beat/min) (10th minute in the ischemic period) 104.85±14.45 110.70±11.96 0.172
Heart rate (beat/min) (30th minute in the reperfusion period)  146.60±8.44 159.70±5.52 <0.001*
pCO2 (mmHg) (Pre-ischemic period)  56.75±5.34 51.50±4.67 0.002*
pCO2 (mmHg) (20
th minute in the ischemic period)  54.55±5.10 49.90±4.64 0.005*
pCO2 (mmHg) (20
th minute in the reperfusion period)  41.00±4.57 45.55±7.35 0.025*
Lactate (mmHg) (Pre-ischemic period)  3.18±0.90 4.20±1.01 0.002*
Lactate (mmHg) (20th minute in the ischemic period)  5.22±0.60 5.19±0.79 0.890
Lactate (mmHg) (20th minute in reperfusion period)  6.85±0.83 7.06±0.70 0.383
Glucose (mg/dL) (Pre-ischemic period)  200.25±49.38 197.65±31.21 0.843
Glucose (mg/dL) (20th minute in the ischemic period)  247.65±44.31 272.55±44.31 0.084
BUN (mg/dL) (Pre-ischemic period) 32.25±5.83 30.15±4.46 0.209
BUN (mg/dL) (20th minute in the reperfusion period)  33.45±6.34 30.65±4.93 0.128
PH (20th minute in the reperfusion period)  7.34±0.05 7.32±0.12 0.513
Hct (20th minute in the reperfusion period) 26.20±2.46 25.35±2.80 0.314
Histopathological scoring 3.20±0.89 2.60±0.68 0.02*
* Statistically significant values
pH: blood acidity; BUN: blood urea nitrogen; pCO2: arterial partial carbon dioxide pressure; pO2: arterial partial oxygen pressure; Glucose: blood glucose; Hct: blood lactate 
and hematocrit 
Table 1. Statistically data with matched normal dissociation
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favorable effects on renal ischemia. However, it has been reported 
that oral administration might presystemically and systemically be 
largely eliminated by bacteria and arginases (18).
While adenosine triphosphate (ATP) decreases due to renal isch-
emia, ATP products such as adenosine, inosine, and hypoxanthine 
increase (11, 12). Endothelium injury in renal ischemia leads to an 
increase in vasoconstrictor substances such as endothelin but a 
decrease in vasodilator substances such as NO (19). Lopez-Neb-
lina et al. (20) conducted a study in rats and demonstrated that 
nitroprusside has a protective effect on serum creatinine level but 
that this protective effect is not observed with L-arginine. There 
are studies reporting that NO-dependent improvement in I/R de-
pends on intact endothelium as well as L-arginine consumption.
Procedures that focus on reducing renal ischemia or metabolic 
needs during ischemia are implemented to preserve renal func-
tions during aortic surgery in humans. It is stated that enhancing 
cardiac performance, low-dose dopamine support, hypothermia, 
and using vasodilator and antioxidant drugs play a protective 
role against the development of renal complications (21).
CONCLUSION
The present study determined fewer histopathological changes 
and lower mean scores in the L-arginine group compared with 
those in the control group in the rabbits in which a renal ischemia–
reperfusion model was created by aortic clamping (2.60±0.68 vs. 
3.2±0.89, respectively; p=0.022). Moreover, a statistically signifi-
cant decrease was observed in terms of 48th hour BUN and serum 
creatinine levels in the L-arginine group compared with those 
in the control group (55.85±14.92 vs. 94.50±28.66, respectively; 
p<0.001) (1.03±0.11 vs. 1.16±0.14, respectively; p=0.003). Based 
on the data and results of the present study, it can be suggested 
that L-arginine, which is administered as an intravenous infusion 
over the course of the renal ischemic period, protects the kidneys 
from I/R injury.
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